MS

Novartis sues FDA over its stance on Sanofi blockbuster’s exclusivity
Endpoints
Tue, 03/9/21 - 10:49 am
Novartis
generics
Sandoz
FDA
Aubagio
multiple sclerosis
MS
Novartis study: Nurses and MS patients give thumbs-up to Kesimpta for ease of use
Fierce Pharma
Wed, 03/3/21 - 10:58 am
Novartis
Kesimpta
MS
multiple sclerosis
MS study points to the gut microbiome as a potential source of the disease
Fierce Biotech
Mon, 02/8/21 - 10:47 am
MS
multiple sclerosis
microbiome
IL-17
Biogen to pay $22 million to resolve U.S. drug charity kickback probe
Reuters
Thu, 12/17/20 - 06:30 pm
Biogen
MS
kickbacks
Medicare
multiple sclerosis
Roche's MS blockbuster Ocrevus, facing new Novartis competition, scores FDA nod for more-convenient infusion
Fierce Pharma
Tue, 12/15/20 - 08:29 pm
Roche
Novartis
Kesimpta
Ocrevus
MS
multiple sclerosis
TG adds a multiple sclerosis string to its bow
EP Vantage
Fri, 12/11/20 - 11:07 am
TG Therapeutics
hematology
ASH2020
ublituximab
MS
multiple sclerosis
MediciNova's Ibudilast Reduces Retinal Thinning in MS Trial Subjects
BioSpace
Wed, 11/25/20 - 10:38 am
MediciNova
OCT
clinical trials
ibudilast
MS
multiple sclerosis
retinal thinning
Biogen finally culls MS dud opicinumab, adds SMA gene therapy to the garbage heap
Fierce Biotech
Wed, 10/21/20 - 10:58 am
Biogen
earnings
opicinumab
MS
SMA
BIIB089
'Uninhibited' price hikes, lobbying and more: Congressional probe gives detailed look into Teva's long run with Copaxone
Fierce Pharma
Wed, 09/30/20 - 10:26 am
Teva Pharmaceutical
Copaxone
congress
MS
drug pricing
competition
Novartis set to take on Roche as FDA clears first at-home, injectable MS drug
Biopharma Dive
Thu, 08/20/20 - 10:52 pm
Novartis
FDA
Kesimpta
ofatumumab
MS
multiple sclerosis
Teva shares slide as it faces illegal kickback charges from US government
Pharmaforum
Thu, 08/20/20 - 10:59 am
Teva Pharmaceutical
kickbacks
DOJ
Copaxone
MS
multiple sclerosis
Mylan launches first generic to Tecfidera in multiple sclerosis
Seeking Alpha
Wed, 08/19/20 - 09:26 am
Mylan
generics
Tecfidera
Biogen
MS
multiple sclerosis
U.S. court upholds patent for Novartis MS drug Gilenya
Reuters
Tue, 08/18/20 - 11:04 am
Novartis
patents
Gilenya
MS
multiple sclerosis
Sanofi, seeking control of key drug, to buy Principia for $3.7B
BioPharma Dive
Mon, 08/17/20 - 01:03 pm
Sanofi
Principia Biopharma
M&A
multiple sclerosis
MS
SAR442168
Immunic's lead MS drug hits primary and key secondary endpoints in PhII, but questions remain
Endpoints
Mon, 08/3/20 - 10:22 am
Immunic
MS
multiple sclerosis
clinical trials
IMU-838
Biogen points to COVID-19 for disappointing drug launch
BioPharma Dive
Wed, 07/22/20 - 11:42 pm
Biogen
Vumerity
MS
multiple sclerosis
Roche, PicnicHealth start RWD partnership with multiple sclerosis focus
MedCity News
Mon, 07/20/20 - 10:32 am
Roche
PicnicHealth
MS
multiple sclerosis
RWD
real world data
artificial intelligence
Bristol Myers Pays Dragonfly $55M to Bring NK Cells to Neuro Diseases
Xconomy
Mon, 07/6/20 - 10:48 am
Bristol-Meyers Squibb
Dragonfly Therapeutics
multiple sclerosis
MS
neuroinflammation
Mylan, looking to capitalize on Biogen's Tecfidera patent loss, faces fork in the road on generic launch
Fierce Pharma
Mon, 06/22/20 - 08:36 pm
Biogen
Tecfidera
Mylan
patents
generics
MS
multiple sclerosis
Judge wipes out Biogen's Tecfidera patent protections in suit against Mylan
Fierce Pharma
Thu, 06/18/20 - 10:44 am
Biogen
Mylan
Tecfidera
patents
MS
multiple sclerosis

Pages